François Depasse

1.9k total citations
40 papers, 1.1k citations indexed

About

François Depasse is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, François Depasse has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 17 papers in Cardiology and Cardiovascular Medicine and 15 papers in Internal Medicine. Recurrent topics in François Depasse's work include Blood Coagulation and Thrombosis Mechanisms (15 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Atrial Fibrillation Management and Outcomes (13 papers). François Depasse is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (15 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Atrial Fibrillation Management and Outcomes (13 papers). François Depasse collaborates with scholars based in France, United States and Germany. François Depasse's co-authors include M Samama, Elisabeth Perzborn, Céline Guinet, Geneviève Plu‐Bureau, Ismaı̈l Elalamy, Grigoris Gerotziafas, Tahar Chakroun, Peter L. Turecek, Nikolaus B. Binder and Stephan Schwers and has published in prestigious journals such as Blood, Journal of Chromatography A and Anesthesiology.

In The Last Decade

François Depasse

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by François Depasse

Since Specialization

Citations

This map shows the geographic impact of François Depasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Depasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Depasse more than expected).

Fields of papers citing papers by François Depasse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Depasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Depasse. The network helps show where François Depasse may publish in the future.

Co-authorship network of co-authors of François Depasse

This figure shows the co-authorship network connecting the top 25 collaborators of François Depasse. A scholar is included among the top collaborators of François Depasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Depasse. François Depasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Contact phase inhibitors: the future of anticoagulation? 2025 ·Journal of Laboratory Medicine ·(unknown), François Depasse, (unknown)	1
2	Clinical use of thrombin generation assays 2021 ·Journal of Thrombosis and Haemostasis ·Nikolaus B. Binder, François Depasse, (unknown), (unknown), Stephan Schwers, Matthias Germer, (unknown), Peter L. Turecek	69
3	Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine 2021 ·Journal of Thrombosis and Haemostasis ·François Depasse, Nikolaus B. Binder, (unknown), (unknown), Stephan Schwers, Matthias Germer, (unknown), Peter L. Turecek	56
4	Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples 2020 ·International Journal of Laboratory Hematology ·(unknown), (unknown), (unknown), François Depasse, (unknown), G. Contant, Olivier Mathieu	20
5	Determination of edoxaban equivalent concentrations in human plasma by an automated anti-factor Xa chromogenic assay 2017 ·Thrombosis Research ·Ling He, Jarema Kochan, Min Lin, Alexander G. Vandell, Karen Brown, François Depasse	26
6	Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor 2010 ·Thrombosis and Haemostasis ·(unknown), (unknown), Céline Guinet, Geneviève Plu‐Bureau, François Depasse, Elisabeth Perzborn, M Samama	366
7	Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: A randomised controlled trial in healthy elderly adults 2010 ·Thrombosis Research ·M Samama, Satoshi Kunitada, (unknown), François Depasse, Stan Heptinstall	19
8	Deux nouveaux anticoagulants disponibles en 2010 – Dabigatran Etexilate et Rivaroxaban: progrès attendus – problèmes posés 2010 ·Annales Pharmaceutiques Françaises ·M Samama, J. Conard, M.H. Horellou, Léna Le Flem, C. Guinet, François Depasse	5
9	Des anciens aux nouveaux anticoagulants: le rôle du biologiste 2009 ·Annales de biologie clinique ·(unknown), François Depasse	3
10	The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices 2005 ·Transfusion and Apheresis Science ·François Depasse, Luc Sensebé, Jerard Seghatchian, Georges Andreu, Meyer‐Michel Samama	29
11	Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay 2005 ·Thrombosis Journal ·Grigoris Gerotziafas, François Depasse, (unknown), (unknown), Ismaı̈l Elalamy, M Samama	108
12	Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma 2004 ·Blood Coagulation & Fibrinolysis ·Grigoris Gerotziafas, François Depasse, Tahar Chakroun, Patrick Van Dreden, M Samama, Ismaı̈l Elalamy	34
13	Proteomics of methylene blue photo‐treated plasma before and after removal of the dye by an absorbent filter 2004 ·PROTEOMICS ·David Crettaz, Luc Sensebé, (unknown), Philippe Schneider, François Depasse, Willy V. Bienvenut, Manfredo Quadroni, Jean‐Daniel Tissot	39
14	The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation 2004 ·Thrombosis and Haemostasis ·Tahar Chakroun, François Depasse, (unknown), M Samama, Ismaı̈l Elalamy, Grigoris Gerotziafas	39
15	Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood 2004 ·Thrombosis and Haemostasis ·François Depasse, Tahar Chakroun, M Samama, Ismaı̈l Elalamy, Grigoris Gerotziafas	41
16	Comparative study of the pharmacokinetic profiles of two LMWHs—bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)—administered subcutaneously to healthy male volunteers 2003 ·Thrombosis Research ·François Depasse, (unknown), (unknown), J. Fontcuberta, M. Borrell, M Samama	28
17	On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma 2003 ·Blood Coagulation & Fibrinolysis ·Grigoris Gerotziafas, Ismaı̈l Elalamy, François Depasse, Tahar Chakroun, L. Bara, (unknown), M Samama	6
18	[Heparin-induced thrombocytopenia]. 2000 ·PubMed ·François Depasse, (unknown)	2
19	Un cas rare d'allongement du TCA: le déficit en prékallicréine 2000 ·Immuno-analyse & Biologie Spécialisée ·François Depasse	1
20	Determination of iodide in serum and urine by ion-pair reversed-phase high-performance liquid chromatography with coulometric detection 1995 ·Journal of Chromatography B Biomedical Sciences and Applications ·Fathi Moussa, M C Raux-Demay, (unknown), François Depasse, Ridha Gharbi, (unknown), P Aymard	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact